YPrime in Action:
A Pediatric Epilepsy Study  

A biotech company embarked on a groundbreaking study to tackle pediatric epilepsy—a condition where current treatments fall short in long-term efficacy. Faced with the intricacies of global regulations and the need for a sophisticated eCOA platform, this sponsor turned to YPrime for their expertise and support.

This case study showcases YPrime’s role as a pivotal partner in advancing pediatric epilepsy research through expert guidance and a highly configurable eCOA solution.

Discover how we can help you navigate the intricacies and challenges of complex indications and solve for certainty with our eCOA platform. Download the case study today.